The KK125 Ovarian Cancer Research Foundation was formed in December 2013 to focus on reforming compassionate use, advancing treatments and cures for ovarian cancer, and promoting the early detection of ovarian cancer.
The mortality rate for ovarian cancer is abysmal - 22,000 women are diagnosed annually, and 14,000 of them die in the same year.
The disease has such vague symptoms that women don't recognize the manifestation of the disease until it is too late, and women are not regularly screened for the disease as they are for cervical and breast cancer.
Early detection and intervention raise the odds of remission to over 90%.
Ovarian cancer is almost always diagnosed at an advanced stage, making it difficult to impossible to successfully treat.